Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

First-Line ADCs in Metastatic Triple-Negative Breast Cancer
First-Line ADCs in Metastatic Triple-Negative Breast Cancer
On the Frontlines of Metastatic Breast Cancer
First-Line ADCs in Metastatic Triple-Negative Breast Cancer
Alexandria May, PharmD, BCPS; Heather McArthur, MD, MPH, FASCO
- Alexandria May, PharmD, BCPS
- Heather McArthur, MD, MPH, FASCO
The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
CME/CE
The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
Solange Peters, MD, PhD
0.50 credits
- Solange Peters, MD, PhD
0.50 credits
Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Clinician's Roundtable
Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Brian P. McDonough, MD, FAAFP; David A. Johnson, MD, FACG, FACP
- Brian P. McDonough, MD, FAAFP
- David A. Johnson, MD, FACG, FACP
Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Project Oncology®
Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Steve Jackson, PharmD; Paolo F. Caimi, MD
- Steve Jackson, PharmD
- Paolo F. Caimi, MD
- Narendranath Epperla, MD, MS
Molecular Testing in Advanced Non-Small Cell Lung Cancer
Molecular Testing in Advanced Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung Cancer
Molecular Testing in Advanced Non-Small Cell Lung Cancer
Alexandria May, PharmD, BCPS; Timothy F. Burns, MD, PhD
- Alexandria May, PharmD, BCPS
- Timothy F. Burns, MD, PhD
How ALK Vaccines Could Prolong TKI Response in mNSCLC
How ALK Vaccines Could Prolong TKI Response in mNSCLC
Project Oncology®
How ALK Vaccines Could Prolong TKI Response in mNSCLC
Angel Qin, MD
- Angel Qin, MD
Patterns of Progression and Resistance in ALK+ mNSCLC
Patterns of Progression and Resistance in ALK+ mNSCLC
Project Oncology®
Patterns of Progression and Resistance in ALK+ mNSCLC
Alice T. Shaw, MD, PhD
- Alice T. Shaw, MD, PhD
Advancing Metastatic Breast Cancer Research Through Philanthropy
Advancing Metastatic Breast Cancer Research Through Philanthropy
On the Frontlines of Metastatic Breast Cancer
Advancing Metastatic Breast Cancer Research Through Philanthropy
Steve Jackson, PharmD; Ted Giovanis, FHFMA, MBA
- Steve Jackson, PharmD
- Ted Giovanis, FHFMA, MBA

Medical News

Medical News
Voice and Swallowing Training After Laryngeal Cancer Surgery
10/23/2026
Read more
Medical News
FLARE Intervention Improves Sun Protection in Children
10/23/2026
Read more
Medical News
AI Endoscopic Depth Assessment for Early Gastric Cancer
10/22/2026
Read more
Medical News
AI Model Predicts Colorectal Cancer Nodal Metastasis
10/16/2026
Read more

CME/CE

CME/CE In-Person & Virtual Event
Spotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice
December 5, 2026
Scottsdale, Arizona
1.00 credit
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
MinuteCE®
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
Komal Jhaveri, MD, FACP; Virginia Kaklamani, MD, DSc
0.50 program credits
- Komal Jhaveri, MD, FACP
- Virginia Kaklamani, MD, DSc
0.50 program credits
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
MinuteCE®
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
Virginia Kaklamani, MD, DSc
0.50 program credits
- Virginia Kaklamani, MD, DSc
0.50 program credits
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
MinuteCE®
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
Natalie S. Callander, MD
0.75 program credits
- Natalie S. Callander, MD
0.75 program credits

Clinical Practice

Zidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
Zidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung Cancer
Zidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
Ryan Quigley; Alexander Drilon, MD
- Ryan Quigley
- Alexander Drilon, MD
Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
Project Oncology®
Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
John Cho, MD, PhD, FRCPC
- John Cho, MD, PhD, FRCPC
How Novel Strategies Could Push ALK+ mNSCLC Care Forward
How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Project Oncology®
How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Angel Qin, MD
- Angel Qin, MD
Interpreting Oral SERD Trial Data in Metastatic Breast Cancer
Interpreting Oral SERD Trial Data in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Interpreting Oral SERD Trial Data in Metastatic Breast Cancer
Alexandria May, PharmD, BCPS; Donald McDonnell, PhD
- Alexandria May, PharmD, BCPS
- Donald McDonnell, PhD
- Neil M. Iyengar, MD

Programs

From Evidence to Practice: Advances in Malignant Pleural Effusion Management
From Evidence to Practice: Advances in Malignant Pleural Effusion Management
Clinician's Roundtable
From Evidence to Practice: Advances in Malignant Pleural Effusion Management
Nicholas Pastis, MD
- Nicholas Pastis, MD
Guiding mNSCLC Treatment After ALK-TKI Progression
Guiding mNSCLC Treatment After ALK-TKI Progression
Project Oncology®
Guiding mNSCLC Treatment After ALK-TKI Progression
Alice T. Shaw, MD, PhD
- Alice T. Shaw, MD, PhD
Investigating Unanswered Questions in ALK+ mNSCLC Care
Investigating Unanswered Questions in ALK+ mNSCLC Care
Project Oncology®
Investigating Unanswered Questions in ALK+ mNSCLC Care
Alice T. Shaw, MD, PhD
- Alice T. Shaw, MD, PhD
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Project Oncology®
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Alexandria May, PharmD, BCPS; Shannon Raber, MS, CPNP, RN
- Alexandria May, PharmD, BCPS
- Shannon Raber, MS, CPNP, RN
- Bridget Archambault, MSN, CPNP